Physician profile
Samuel A Uter
NPI 1699713792
$135,979.64
in general payments reported to CMS, 2019-2025
20 companies · $34.51 in 2025
The $34.51 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59K · 2020: $20K · 2021: $18K · 2022: $18K · 2023: $17K · 2024: $4,245 · 2025: $34.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Food and Beverage: $2,259 · Travel and Lodging: $1,188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,410.00 |
| Food and Beverage | $2,259.20 |
| Travel and Lodging | $1,188.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $45,303.53 | 2019-2025 | Mavyret |
| Janssen Products, LP | $41,793.10 | 2019-2023 | Symtuza |
| Gilead Sciences, INC. | $29,206.48 | 2019-2024 | Biktarvy |
| Viiv Healthcare Company | $15,114.92 | 2019-2024 | Dovato, Cabenuva, Apretude |
| Janssen Biotech, INC. | $2,324.04 | 2019-2023 | Symtuza |
| Theratechnologies INC. | $1,747.27 | 2019-2023 | Egrifta, Trogarzo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.88 | 2019 | |
| Global Blood Therapeutics, INC. | $65.63 | 2020-2021 | |
| Glaxosmithkline, LLC. | $49.55 | 2024 | Shingrix |
| Pfizer INC. | $48.75 | 2019-2021 | |
| Novo Nordisk INC | $46.61 | 2021-2023 | Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $25.36 | 2024 | |
| Amarin Pharma, INC. | $20.32 | 2021 | |
| Exact Sciences Corporation | $19.80 | 2023 | Cologuard Collection Kit |
| Lilly USA, LLC | $19.75 | 2023 | Jardiance |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cequr Corporation | $19.36 | 2024 | Cequr Simplicity |
| Amgen INC. | $19.33 | 2022 | |
| Allergan, INC. | $18.02 | 2020 | |
| Dexcom, INC. | $14.94 | 2024 | Dexcom G6 Transmitter |
| Janssen Scientific Affairs, LLC | $14.00 | 2023 | Symtuza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Uter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.